Psychedelic Medicine

Some people find their symptoms of OCD dramatically drop after smoking cannabis, according to a new study. The improvements may only be beneficial in the short-term however, and more research is needed to understand the long-term effect of cannabis use on OCD.

An incredible, first-of-its-kind trial testing the pain-killing properties of LSD microdoses has delivered the compelling suggestion that tiny, non-psychedelic doses of this infamous drug could serve as an effective analgesic.

A novel clinical trial is set to explore the subjective effects of combining LSD and MDMA. The primary goal is to investigate whether MDMA can reduce some negative mood effects seen with LSD and improve outcomes for psychedelic-assisted psychotherapy.

A new study, led by researchers from University College London, is offering some of the first robust evidence showing how CBD, a key compound in cannabis, increases cerebral blood flow in memory processing regions of the brain such as the hippocampus.

Four terminally ill cancer patients in Canada have been granted a special exemption to legally possess and consume psilocybin. They are the first in the country, outside a clinical trial, allowed to do so since the psychedelic was made illegal in 1974.

Positive results from the world’s first clinical trial testing the potential for cannabidiol (CBD) to treat cannabis addiction suggest daily use of medical-grade CBD is both safe and effective at reducing problematic cannabis consumption.

A new review is suggesting psilocybin may have great potential as a treatment for OCD. The review sums up the current evidence arguing psychedelic therapy should be effective for OCD in the same way it has shown efficacy treating depression and anxiety.

The state of Oregon will officially vote on legalizing psilocybin psychotherapy in the upcoming November election. The initiative focuses solely on licensed and regulated psychedelic-assisted psychotherapy in clinical environments.

New research is offering the first clinical trial insights into microdosing THC to treat chronic pain. The results of the small trial suggest tiny doses of THC may confer clinically apparent reductions in pain without inducing psychoactive effects.

A new pilot study has demonstrated nitrous oxide, commonly known as laughing gas, may help military veterans suffering from PTSD. A larger trial is now underway after several studies demonstrated potential new uses for the gas.

A study has found smoking high-THC marijuana or concentrates does not result in greater levels of intoxication. The research adds weight to a body of evidence suggesting proposed roadside THC tests may not correlate with driving impairment.

A new Johns Hopkins study, looking at how psilocybin influences a mysterious brain region called the claustrum, is just one of several compelling recent articles shining a light on how our brains generate our experience of consciousness.